Drug recall · May 29, 2013
Lamisil AT recall
Why: Labeling: Incorrect or Missing Lot and/or Expiration date; The Lot and/or Expiration date on the tube may not be legible in this lot.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Lamisil AT (terbinafine hydrochloride cream 1% antifungal), 24 g (.85 oz) tube, Novartis Consumer Health, Parsippany, NJ 07054, NDC 0067-6171-85
- Lots / codes
Lot #: 10118124, Exp: Sept 2013
- Quantity
- 3,828 Tubes
- Company
- Novartis Consumer Health, Lincoln, NE
- Distribution
- Nationwide
- Initiated
- April 19, 2013 · Voluntary: Firm initiated
- Classified
- May 17, 2013
- Reported
- May 29, 2013
- Ended
- November 4, 2014
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Terbinafine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.